U.S. Food and Drug Administration (FDA) Grants Full Approval for ELAHERE® (mirvetuximab soravtansine-gynx) for Certain Ovarian Cancer Patients

– The full approval of ELAHERE is based on the confirmatory MIRASOL Phase 3 trial that supports the medicine as a potential new standard of care for folate receptor alpha (FRα)-positive, platinum-resistant ovarian cancer (PROC)

– Data show that ELAHERE treatment resulted in an overall survival benefit and reduced the risk of cancer progression by 35%

– ELAHERE represents AbbVie’s first approved solid tumor treatment following the recent acquisition of ImmunoGen

Read More

AT&T Responds to Data Breach Concerns from Dark Web Release

AT&T is responding to a data set release on the dark web by launching an investigation. The company confirms that specific data fields were included and estimates around 7.6 million current and 65.4 million former account holders were affected. AT&T reassures customers of its commitment to data security and plans to enhance cybersecurity measures.

Read More

United becomes first airline to add new larger air tanks to Embraer E175

United Airlines introduces larger air tanks on Skywest – the Embraer E175 aircraft, offering 80% more space. This initiative aims to enhance passenger comfort and operational efficiency by reducing the need for gate-checking carry-on bags. United plans to implement these improvements on 150 aircraft by 2026, reflecting their commitment to innovation and customer satisfaction.

Read More